James D Lord

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Systemic Sclerosis

Disease Activity

Interstitial Lung Disease

Top Venues

The Journal of experimental medicine

Journal of Crohn's & colitis

Inflammatory bowel diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Andrew J Konecny, Donna M Shows, James D Lord
Colonic mucosal associated invariant T cells in Crohn's disease have a diverse and non-public T cell receptor beta chain repertoire. PloS one 18 (11) (2023)
Duncan C Hindmarch, Sofya Malashanka, Donna M Shows, Astrid S Clarke, James D Lord
Janus kinase inhibitors differentially inhibit specific cytokine signals in the mesenteric lymph node cells of IBD patients. Journal of Crohn's & colitis (2023)
Elisa K Boden, Ramya Kongala, Duncan C Hindmarch, Donna M Shows, Julius G Juarez, James D Lord
Vedolizumab Efficacy Is Associated With Decreased Intracolonic Dendritic Cells, Not Memory T Cells. Inflammatory bowel diseases (2023)
Oyebola O Oyesola, Michael T Shanahan, Matt Kanke, Bridget M Mooney, Lauren M Webb, Shuchi Smita, Macy K Matheson, Pamela Campioli, Duc H Pham, Simon P Früh, John W McGinty, Madeline J Churchill, Jordan L Cahoon, Pavithra Sundaravaradan, Becca A Flitter, Karthik Mouli, Marija S Nadjsombati, Elena Kamynina, Seth A Peng, Rebecca L Cubitt, Karsten Gronert, James D Lord, Isabella Rauch, Jakob von Moltke, Praveen Sethupathy, Elia D Tait Wojno
PGD2 and CRTH2 counteract Type 2 cytokine-elicited intestinal epithelial responses during helminth infection. The Journal of experimental medicine 218 (9) (2021)